GRDNGuardian Pharmacy Services, Inc.
Price
+62%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, nothing alarming, demanding price, growing in the filings, the market undecided.
We are a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. We emphasize high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as assisted living facilities (“ALFs”), and behavioral health facilities and group homes (collectively “BHFs”).
In the company’s own words · 10-K filed Mar 11, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Guardian Pharmacy Services, Inc. (GRDN) reported revenue of $352M in Q2 2026 (quarter ended Jun 30, 2026), up 2.2% from the same quarter a year earlier. That came with a gross margin of 23% and net income of $22M (6.2% of revenue). For the full year FY2025, revenue was $1.45B (+18% year on year) and net income $49M. The next results filing is expected around Nov 9, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Sep 10, 2026Common Stock Lock-Up Agreements with Certain Holders Effective September 10, 2026, Guardian Pharmacy Services, Inc. (the “Company”) entered into lock-up agreements with its founders, executive officers and certain other employees (the “Lock-Up Holders”) who hold shares of the Company’s Class A common stock.Other event · Form 8-K
- Aug 6, 2026Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance.Earnings release · press release
- Jun 22, 2026On June 22, 2026, Guardian Pharmacy Services, Inc. (the “Company”) announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since the Company was founded in 2004, will retire from all positions with the Company effective July 1, 2026.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Care Facilities
The closest names by size in the same industry